A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. 1993

J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
Sir William Dunn School of Pathology, University of Oxford, United Kingdom.

CD4 is the primary receptor for the human immunodeficiency virus type 1 (HIV-1). Early mutational studies implicated a number of residues of CD4, centered in the region 41-59, in binding to gp120. However, further mutational analyses, together with studies using inhibitory antibodies or CD4-derived peptides, have suggested that other regions of CD4 are also involved in binding or postbinding events during infection. To resolve these ambiguities, we used rat CD4 mutants in which particular regions were replaced with the corresponding sequence of human CD4. We have previously shown that some of these are able to bind HIV-1 gp120, and here we test their ability to act as functional receptors. We find that the presence of human CD4 residues 33-62 is enough to confer efficient receptor function to rat CD4, and we conclude that it is unlikely that regions of CD4 outside this sequence are involved in specific interactions with HIV-1 during either infection or syncytium formation.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III

Related Publications

J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
January 1992, The Journal of experimental medicine,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
July 1993, Journal of virology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
November 2010, Chemical communications (Cambridge, England),
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
September 1994, Journal of virology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
December 1995, Journal of clinical microbiology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
June 2001, Journal of virology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
November 1991, Virology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
August 2007, Journal of virology,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
April 1992, AIDS research and human retroviruses,
J H Simon, and C Somoza, and G A Schockmel, and M Collin, and S J Davis, and A F Williams, and W James
June 2007, Virology,
Copied contents to your clipboard!